Antibody Technologies Market Analysis and Value Forecast Snapshot by End-use Industry 2017-2025

Antibodies are referred as proteins produced by plasma cells of the body which are used by immune system to identify and fight against foreign bodies entering the host body. Antibodies are also known as immunoglobulin (Ig). Antibodies are of Y shaped with specific binding site for specific antigen, a foreign body that provokes an adaptive immune response. Antibodies are secreted by type of white blood cells (WBCs) namely, plasma cells.

Get PDF Brochure for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33962

Immunity strength is observed to be directly proportional to age. With aging of population, the number of patients suffering diseases caused by weak immunity is increasing. Thus, factors such as global increase in the geriatric population, increasing research and development activity in the immunology field and availability of the government funds for research activities are driving the global antibody technologies market towards growth. On the other hand, lack of funds in developing economies, stringent regulatory framework and poor adoption of new technologies are some of the factors restraining the growth of the global antibody technologies market.

Based on the type of antibody, the global antibody technologies market is segmented as follows:
Intravenous immunoglobulin (IVIg)
Microantibody
Single-domain antibody
Anti-mitochondrial antibodies
Secondary antibodies
Monoclonal antibody (mAb or moAb)
Anti-nuclear antibodies
Neutralizing antibody
Others

Based on applications, the global antibody technologies market is segmented as follows:
Medical application
Disease diagnosis
Therapy
Prenatal therapy
Immunotherapy
Antibody therapy
Research applications
Proteins
Flow cytometry
Immunoprecipitation
Immunochemistry
Immunoprecipitation
Immunofluorescence
Others

On the grounds of increased research and development activities globally, immunofluorescence is the fastest growing segment among the available research applications. Disease diagnosis segment is leading the medical application segment due to advancements in research and thereby entry of improved techniques in the market. Monoclonal antibodies (mAb or moAb) is leading the segment and is followed by Intravenous immunoglobulin (IVIg) in the antibody type based antibody technology segment.

Geographically, the global antibody technologies market is categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America currently leads global antibody technologies market and is followed by Europe. Factors that are fueling the growth of antibody technology market in the North America include existence of highly advanced technologies, early adoption of new technologies, developed healthcare infrastructure and supportive economy. Asia-Pacific is a lucrative market for antigen technologies and is predicted to undergo fast market growth. Particularly, countries such as India and China show growth potential, owing to factors such as government support to develop biotechnology industry in respective countries, rapidly improving healthcare infrastructure and increased healthcare spending. In addition, Asia Pacific countries mainly India and China will attract patients on the grounds of rapidly developing medical tourism industry in these countries and thereby resulting in increased demand for antibody technologies market in this region.

Request for an in-depth table of contents for this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=33962

Some of the major players contributing to the global antibody technologies market include, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Biotest AG, Shanghai RAAS Blood Products Co. Ltd., China Biologic Products, Inc., Bharat Serums and Vaccines Ltd., OMRIX Biopharmaceuticals Ltd., Kedrion S.p.A, Beijing Tiantan Biological Products Co. Ltd., Huanlan Biological Engineering, Inc., Guizhou Taibang Biological Products Co. Ltd., Grifols S.A., CSL Behring LLC, Baxter International, Inc. and Octapharma AG.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
90 State Street,
Suite 700
Albany NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
E-mail: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.